Search

Your search keyword '"PRIONS"' showing total 20,970 results

Search Constraints

Start Over You searched for: Descriptor "PRIONS" Remove constraint Descriptor: "PRIONS"
20,970 results on '"PRIONS"'

Search Results

1. Precision proteoform design for 4R tau isoform selective templated aggregation

2. Ecology and Chronic Wasting Disease Epidemiology Shape Prion Protein Gene Variation in Rocky Mountain Elk (Cervus elaphus nelsoni)

3. Viroids, Satellite RNAs and Prions: Folding of Nucleic Acids and Misfolding of Proteins.

4. Severe neurodegeneration in brains of transgenic rats producing human tau prions

5. PMCA to demonstrate the efficacy of prion inactivation methods on reusable medical devices: a relevant alternative to animal bioassays.

6. Determination of prion proteins in the diagnosis of Creutzfeldt-Jakob disease using RT-QuIC: A case report from northeastern Colombia.

7. Unsuccessful transmissions of atypical genetic Creutzfeldt–Jakob disease (PRNP p.T183A-129M) in transgenic mice.

8. Species barrier as molecular basis for adaptation of synthetic prions with N‐terminally truncated PrP.

9. Bioengineered self-assembled nanofibrils for high-affinity SARS-CoV-2 capture and neutralization.

10. Sodium hypochlorite inactivation of human CJD prions.

11. Intrinsically Disordered Compositional Bias in Proteins: Sequence Traits, Region Clustering, and Generation of Hypothetical Functional Associations.

12. A novel ER stress regulator ARL6IP5 induces reticulophagy to ameliorate the prion burden.

13. Lead Acetate Exposure and Cerebral Amyloid Accumulation: Mechanistic Evaluations in APP/PS1 Mice.

14. A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts.

15. Temporal Characterization of Prion Shedding in Secreta of White-Tailed Deer in Longitudinal Study of Chronic Wasting Disease, United States.

16. PrP is cleaved from the surface of mast cells by ADAM10 and proteases released during degranulation.

17. Zoonotic Potential of Chronic Wasting Disease after Adaptation in Intermediate Species

18. Expression of the cellular prion protein by mast cells in white-tailed deer carotid body, cervical lymph nodes and ganglia

19. Determination of prion proteins in the diagnosis of Creutzfeldt-Jakob disease using RT-QuIC: A case report from northeastern Colombia

20. Temporal Characterization of Prion Shedding in Secreta of White-Tailed Deer in Longitudinal Study of Chronic Wasting Disease, United States

21. [PSI]-CIC: A Deep-Learning Pipeline for the Annotation of Sectored Saccharomyces cerevisiae Colonies: [PSI]-CIC: A Deep-Learning Pipeline...: J. Collignon et al.

22. Prions: structure, function, evolution, and disease.

23. Effects of transmission pathways, immunological thresholds, and long-distance dispersal on infectious spread: chronic wasting disease case study.

24. Chronic wasting disease as a part of animal spongiform encephalopathies.

25. A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts

26. On the Anniversary of the Honorary President of the Vavilov Society of Geneticists and Breeders, Academician Sergei Georgievich Inge-Vechtomov

27. Transmission of Norwegian reindeer CWD to sheep by intracerebral inoculation results in an unusual phenotype and prion distribution

28. The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer's disease.

29. Aqueous extraction of formalin-fixed paraffin-embedded tissue and detection of prion disease using real-time quaking-induced conversion.

30. 1-L Transcription in Prion Diseases.

31. Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents.

32. An autopsy case of MM1‐type sporadic Creutzfeldt–Jakob disease with long survival of 7 years.

33. The molecular determinants of a universal prion acceptor.

34. Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates.

35. Screening of Anti-Prion Compounds Using the Protein Misfolding Cyclic Amplification Technology.

36. Protective role of cytosolic prion protein against virus infection in prion-infected cells.

37. CSF Analysis May Help in the Diagnosis of Dementia with Lewy Bodies.

38. Protein folding, cellular stress and cancer.

39. Molecular Dynamics and Optimization Studies of Horse Prion Protein Wild Type and Its S167D Mutant.

40. "Prion-like" seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders.

41. Propagation of distinct CWD prion strains during peripheral and intracerebral challenges of gene-targeted mice.

42. "Ourselves Writ savage": Disease, Desire, and Colonialism in Kuru Country.

43. Tau, RNA, and RNA-Binding Proteins: Complex Interactions in Health and Neurodegenerative Diseases.

44. Convergent generation of atypical prions in knockin mouse models of genetic prion disease.

45. In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives.

46. Characterisation of European Field Goat Prion Isolates in Ovine PrP Overexpressing Transgenic Mice (Tgshp IX) Reveals Distinct Prion Strains.

47. Adaptation of the protein misfolding cyclic amplification (PMCA) technique for the screening of anti‐prion compounds.

48. Transmission of Norwegian reindeer CWD to sheep by intracerebral inoculation results in an unusual phenotype and prion distribution.

49. Modulating the aggregation of human prion protein PrP106–126 by an indole-based cyclometallated palladium complex.

50. Prion protein E219K polymorphism: from the discovery of the KANNO blood group to interventions for human prion disease.

Catalog

Books, media, physical & digital resources